German pharmaceutical and agrochemical company Bayer saw profits fall again in 2024 and faces another difficult year ahead, ...

Bayer’s New Business Model: Magnitude of Change “I’ve been with the company almost 18 years, and I’ve never been so excited or seen the team energized about an operating model like what we ...

Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares ...